Items where authors include "Newell-Price, J.D.C."

Article

Lawrence, N.R. orcid.org/0000-0002-7560-0268, Keevil, B.G., Elder, C. et al. (6 more authors) (2023) OR30-01: Waking salivary 11-hydroxyandrostenedione and cortisone as a novel non-invasive test for adrenal insufficiency. Journal of the Endocrine Society, 7 (Supplement_1). bvad114.351. ISSN 2472-1972

Tschaidse, L., Reisch, N. orcid.org/0000-0002-7469-6069, Arlt, W. orcid.org/0000-0001-5106-9719 et al. (15 more authors) (2023) Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology, 188 (1). lvac006. pp. 109-117. ISSN 0804-4643

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2020) OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia. Journal of the Endocrine Society, 4 (Supplement_1).

Trainer, P.J., Newell-Price, J.D.C., Ayuk, J. et al. (14 more authors) (2018) A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly. European Journal of Endocrinology, 179 (2). pp. 97-108. ISSN 0804-4643

Amarawardena, W.K.M.G., Liyanarachchi, K.D., Newell-Price, J.D.C. et al. (3 more authors) (2017) Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly. Endocrinology, Diabetes and Metabolism Case Reports, 2017 (1). 170067. ISSN 2052-0573

Proceedings Paper

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 12670 CHAMPAIN study: initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Varughese, M.S., Eltumi, H., Kemp, E.H. et al. (1 more author) (2024) 6589 Antisense oligonucleotides for reducing ACTH secretion in a model of Cushing's disease. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Berry, S., Iqbal, A., Newell-Price, J.D.C. et al. (1 more author) (2024) 6927 Metyrapone to reset the nocturnal cortisol rhythm in Mild Autonomous Cortisol Secretion (MACS) - safety and impact on cardiometabolic risk factors. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Ross, R.J.M., Merke, D.P., Mallappa, A. et al. (14 more authors) (2024) 7061 Incidence of adrenal crisis in Congenital Adrenal Hyperplasia (CAH) patients during a prospective monitored long-term study of modified-release hydrocortisone (MRHC) capsules, (Efmody). In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 7692 Morning cortisol levels in patients with established primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Ramezani-Pour, N., Esfahani, S.H.Z., Pradhananga, S. et al. (3 more authors) (2020) SAT-396 A non-surgical animal model of hypoparathyroidism for testing PTH analogues. In: Journal of the Endocrine Society. ENDO 2020 - Annual Meeting of the Endocrine Society, 28-31 Mar 2020, San Francisco, CA, USA (cancelled). Oxford University Press (for The Endocrine Society) .